IL-31 and IL-31 receptor expression in acute experimental canine atopic dermatitis skin lesions.

Published in: Veterinary dermatology (2021)

The early and transient production of IL-31 by Th cells supports the concept of using IL-31 inhibiting strategies as a proactive therapy to prevent flares of AD skin lesions.

Keyphrases

atopic dermatitis
liver failure
soft tissue
stem cells
oxidative stress
intensive care unit
cell cycle arrest
bone marrow
mesenchymal stem cells
drug induced
smoking cessation
acute respiratory distress syndrome
subarachnoid hemorrhage
endoplasmic reticulum stress
cell therapy